stearylamine has been researched along with Leishmaniasis, Visceral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, N; Banerjee, A; De, M | 1 |
| Ali, N; Roychoudhury, J; Sinha, R | 1 |
2 other study(ies) available for stearylamine and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.
Topics: Amines; Animals; Anti-Bacterial Agents; Cells, Cultured; Cricetinae; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunity, Humoral; Immunologic Factors; Interleukin-10; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Paromomycin; Phosphatidylcholines; Transforming Growth Factor beta | 2011 |
Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
Topics: Amines; Animals; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Proliferation; Cytokines; Drug Resistance; Fluoresceins; Immunity, Humoral; Immunomodulation; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Nitric Oxide; Phosphatidylcholines; Rhodamine 123; Spleen | 2011 |